Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-3-22
pubmed:abstractText
A clinical trial of cyclosporine in patients with steroid-resistant membranous nephropathy (MGN) was conducted. Although MGN remains the most common cause of adult-onset nephrotic syndrome, its management is still controversial. Cyclosporine has been shown to be effective in cases of progressive MGN, but it has not been used in controlled studies at an early stage of the disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0085-2538
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1484-90
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11260412-Adult, pubmed-meshheading:11260412-Cyclosporine, pubmed-meshheading:11260412-Dose-Response Relationship, Drug, pubmed-meshheading:11260412-Drug Resistance, pubmed-meshheading:11260412-Drug Therapy, Combination, pubmed-meshheading:11260412-Female, pubmed-meshheading:11260412-Glomerulonephritis, Membranous, pubmed-meshheading:11260412-Glucocorticoids, pubmed-meshheading:11260412-Humans, pubmed-meshheading:11260412-Immunosuppressive Agents, pubmed-meshheading:11260412-Male, pubmed-meshheading:11260412-Middle Aged, pubmed-meshheading:11260412-Prednisone, pubmed-meshheading:11260412-Prospective Studies, pubmed-meshheading:11260412-Proteinuria, pubmed-meshheading:11260412-Recurrence, pubmed-meshheading:11260412-Retreatment, pubmed-meshheading:11260412-Single-Blind Method, pubmed-meshheading:11260412-Steroids, pubmed-meshheading:11260412-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
pubmed:affiliation
Department of Medicine, University of Toronto, Toronto, Ontario, Canada. daniel.catran@uhn.on.ca
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't